세계의 판크레리파아제 시장 규모, 점유율, 동향 분석 리포트 : 연령별, 유통경로별, 용도별, 지역별 전망과 예측(2023-2030년)

The Global Pancrelipase Market size is expected to reach $2.6 billion by 2030, rising at a market growth of 4.7% CAGR during the forecast period.

Collaborations between pharmaceutical companies, research institutions, and healthcare organizations on an international scale may foster innovation in medicine's development and distribution in the Asia Pacific. Consequently, the Asia Pacific region would acquire nearly 20% of the total market share by 2030. Growing awareness and emphasis on digestive health contribute to recognizing the importance of managing conditions like pancreatic insufficiency. This awareness can drive both patient's and healthcare providers' demand for the medicine.

Advances in molecular biology and genetic profiling contribute to the emergence of personalized medicine. Tailoring treatment plans based on personal patient characteristics enhances the efficacy of therapy, leading to better outcomes. Data analytics and AI-driven technologies aid in analyzing large datasets, identifying patterns, and predicting disease progression. These tools can assist healthcare professionals in making more informed decisions regarding medicinal dosage adjustments and treatment plans. As a result, the ongoing technological advancements are expected to expand market growth. Additionally, a natural decline in pancreatic function often accompanies aging. This decline may result in reduced secretion of digestive enzymes, leading to conditions such as pancreatic insufficiency. Medicine becomes essential to support digestion in these individuals. Older adults may be more prone to medication-induced pancreatitis, a condition where certain medications can lead to inflammation of the pancreas. This medicine is utilized in the management of pancreatitis, irrespective of its cause. Due to the growing proportion of the aging population, the market is expected to grow significantly.

However, High treatment costs can limit access to this medicine for patients, specifically those without adequate insurance coverage or high out-of-pocket expenses. This restriction in access can lead to suboptimal management of pancreatic disorders. Healthcare providers and systems may face challenges in allocating resources to cover the costs of this medicine, especially when managing a large patient population with pancreatic disorders. Due to the above factors, market growth will be hampered in the coming years.

Moreover, the market experienced disruptions in manufacturing processes due to lockdowns, restrictions, and workforce limitations imposed to curb the spread of the virus. These challenges led to temporary production facility closures, affecting the supply of formulations. Remote monitoring of patients on therapy faced challenges, as healthcare providers had to navigate limitations in assessing treatment effectiveness without physical examinations and laboratory tests. As a result, COVID-19 had a moderate impact on the market.

By Age Analysis

On the basis of age, the market is segmented into children and adults & geriatrics. The children's segment acquired a substantial revenue share in the pancreatic market in 2022. Children with cystic fibrosis often require this medicine to compensate for the reduced pancreatic enzyme production. This medicine helps them digest and absorb essential nutrients from food. Children who undergo pancreatic surgery or experience trauma to the pancreas may have reduced enzyme secretion. Some children may have congenital conditions, such as pancreatic agenesis or malformations, resulting in insufficient enzyme production. The medicine addresses enzyme deficiency and facilitates proper digestion in these cases.

By Distribution Channel Analysis

By distribution channel, the market is classified into online pharmacies, hospital pharmacies, and drug store & retail pharmacies. The online pharmacies segment recorded a remarkable revenue share in the market in 2022. Regulations about the sale and distribution of prescription medications vary between countries. Some online pharmacies operate within stringent regulatory frameworks and adhere to established standards, while others may have looser regulations. Online pharmacies may offer various formulations and dosages of this medicine. Patients should ensure they purchase the specific formulation and dosage their healthcare provider prescribes.

By Application Analysis

Based on application, the market is fragmented into chronic pancreatitis, cystic fibrosis, and others. The cystic fibrosis segment garnered a significant revenue share in the market in 2022. Cystic fibrosis often leads to pancreatic insufficiency, where the pancreas produces insufficient digestive enzymes. This medicine is prescribed to compensate for this deficiency, ensuring proper digestion and absorption of nutrients from food. The medicine is a key component in the nutritional management of individuals with cystic fibrosis. It helps prevent malnutrition by supporting the breakdown of nutrients, allowing for better absorption in the digestive system.

By Regional Analysis

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region witnessed the largest revenue share in the market. Increased awareness among healthcare professionals and patients regarding managing pancreatic insufficiency can drive the demand for this medicine. Education initiatives can lead to early diagnosis and timely initiation of appropriate treatment. Focus on patient-centric approaches, including personalized medicine, can drive the demand for this medicine. Tailoring therapy plans based on individual patient profiles and genetic factors can optimize therapy and improve patient outcomes.

List of Key Companies Profiled

• Organon & Co.
• Digestive Care, Inc.
• AbbVie, Inc.
• Vivus LLC
• Laboratorio Opoterapico Argentino S.A.
• Nestle S.A
• Scientific Protein Laboratories, LLC (Hepalink)

Global Pancrelipase Market Report Segmentation

By Age

• Adults & Geriatrics
• Children

By Distribution Channel

• Drug Store & Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Application

• Chronic Pancreatitis
• Cystic Fibrosis
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Pancrelipase Market, by Age
  • 1.4.2 Global Pancrelipase Market, by Distribution Channel
  • 1.4.3 Global Pancrelipase Market, by Application
  • 1.4.4 Global Pancrelipase Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges
• 3.3 Porter Five Forces Analysis

Chapter 4. Global Pancrelipase Market by Age

• 4.1 Global Adults & Geriatrics Market by Region
• 4.2 Global Children Market by Region

Chapter 5. Global Pancrelipase Market by Distribution Channel

• 5.1 Global Drug Store & Retail Pharmacies Market by Region
• 5.2 Global Hospital Pharmacies Market by Region
• 5.3 Global Online Pharmacies Market by Region

Chapter 6. Global Pancrelipase Market by Application

• 6.1 Global Chronic Pancreatitis Market by Region
• 6.2 Global Cystic Fibrosis Market by Region
• 6.3 Global Others Market by Region

Chapter 7. Global Pancrelipase Market by Region

• 7.1 North America Pancrelipase Market
  • 7.1.1 North America Pancrelipase Market by Age
    • 7.1.1.1 North America Adults & Geriatrics Market by Country
    • 7.1.1.2 North America Children Market by Country
  • 7.1.2 North America Pancrelipase Market by Distribution Channel
    • 7.1.2.1 North America Drug Store & Retail Pharmacies Market by Country
    • 7.1.2.2 North America Hospital Pharmacies Market by Country
    • 7.1.2.3 North America Online Pharmacies Market by Country
  • 7.1.3 North America Pancrelipase Market by Application
    • 7.1.3.1 North America Chronic Pancreatitis Market by Country
    • 7.1.3.2 North America Cystic Fibrosis Market by Country
    • 7.1.3.3 North America Others Market by Country
  • 7.1.4 North America Pancrelipase Market by Country
    • 7.1.4.1 US Pancrelipase Market
      • 7.1.4.1.1 US Pancrelipase Market by Age
      • 7.1.4.1.2 US Pancrelipase Market by Distribution Channel
      • 7.1.4.1.3 US Pancrelipase Market by Application
    • 7.1.4.2 Canada Pancrelipase Market
      • 7.1.4.2.1 Canada Pancrelipase Market by Age
      • 7.1.4.2.2 Canada Pancrelipase Market by Distribution Channel
      • 7.1.4.2.3 Canada Pancrelipase Market by Application
    • 7.1.4.3 Mexico Pancrelipase Market
      • 7.1.4.3.1 Mexico Pancrelipase Market by Age
      • 7.1.4.3.2 Mexico Pancrelipase Market by Distribution Channel
      • 7.1.4.3.3 Mexico Pancrelipase Market by Application
    • 7.1.4.4 Rest of North America Pancrelipase Market
      • 7.1.4.4.1 Rest of North America Pancrelipase Market by Age
      • 7.1.4.4.2 Rest of North America Pancrelipase Market by Distribution Channel
      • 7.1.4.4.3 Rest of North America Pancrelipase Market by Application
• 7.2 Europe Pancrelipase Market
  • 7.2.1 Europe Pancrelipase Market by Age
    • 7.2.1.1 Europe Adults & Geriatrics Market by Country
    • 7.2.1.2 Europe Children Market by Country
  • 7.2.2 Europe Pancrelipase Market by Distribution Channel
    • 7.2.2.1 Europe Drug Store & Retail Pharmacies Market by Country
    • 7.2.2.2 Europe Hospital Pharmacies Market by Country
    • 7.2.2.3 Europe Online Pharmacies Market by Country
  • 7.2.3 Europe Pancrelipase Market by Application
    • 7.2.3.1 Europe Chronic Pancreatitis Market by Country
    • 7.2.3.2 Europe Cystic Fibrosis Market by Country
    • 7.2.3.3 Europe Others Market by Country
  • 7.2.4 Europe Pancrelipase Market by Country
    • 7.2.4.1 Germany Pancrelipase Market
      • 7.2.4.1.1 Germany Pancrelipase Market by Age
      • 7.2.4.1.2 Germany Pancrelipase Market by Distribution Channel
      • 7.2.4.1.3 Germany Pancrelipase Market by Application
    • 7.2.4.2 UK Pancrelipase Market
      • 7.2.4.2.1 UK Pancrelipase Market by Age
      • 7.2.4.2.2 UK Pancrelipase Market by Distribution Channel
      • 7.2.4.2.3 UK Pancrelipase Market by Application
    • 7.2.4.3 France Pancrelipase Market
      • 7.2.4.3.1 France Pancrelipase Market by Age
      • 7.2.4.3.2 France Pancrelipase Market by Distribution Channel
      • 7.2.4.3.3 France Pancrelipase Market by Application
    • 7.2.4.4 Russia Pancrelipase Market
      • 7.2.4.4.1 Russia Pancrelipase Market by Age
      • 7.2.4.4.2 Russia Pancrelipase Market by Distribution Channel
      • 7.2.4.4.3 Russia Pancrelipase Market by Application
    • 7.2.4.5 Spain Pancrelipase Market
      • 7.2.4.5.1 Spain Pancrelipase Market by Age
      • 7.2.4.5.2 Spain Pancrelipase Market by Distribution Channel
      • 7.2.4.5.3 Spain Pancrelipase Market by Application
    • 7.2.4.6 Italy Pancrelipase Market
      • 7.2.4.6.1 Italy Pancrelipase Market by Age
      • 7.2.4.6.2 Italy Pancrelipase Market by Distribution Channel
      • 7.2.4.6.3 Italy Pancrelipase Market by Application
    • 7.2.4.7 Rest of Europe Pancrelipase Market
      • 7.2.4.7.1 Rest of Europe Pancrelipase Market by Age
      • 7.2.4.7.2 Rest of Europe Pancrelipase Market by Distribution Channel
      • 7.2.4.7.3 Rest of Europe Pancrelipase Market by Application
• 7.3 Asia Pacific Pancrelipase Market
  • 7.3.1 Asia Pacific Pancrelipase Market by Age
    • 7.3.1.1 Asia Pacific Adults & Geriatrics Market by Country
    • 7.3.1.2 Asia Pacific Children Market by Country
  • 7.3.2 Asia Pacific Pancrelipase Market by Distribution Channel
    • 7.3.2.1 Asia Pacific Drug Store & Retail Pharmacies Market by Country
    • 7.3.2.2 Asia Pacific Hospital Pharmacies Market by Country
    • 7.3.2.3 Asia Pacific Online Pharmacies Market by Country
  • 7.3.3 Asia Pacific Pancrelipase Market by Application
    • 7.3.3.1 Asia Pacific Chronic Pancreatitis Market by Country
    • 7.3.3.2 Asia Pacific Cystic Fibrosis Market by Country
    • 7.3.3.3 Asia Pacific Others Market by Country
  • 7.3.4 Asia Pacific Pancrelipase Market by Country
    • 7.3.4.1 China Pancrelipase Market
      • 7.3.4.1.1 China Pancrelipase Market by Age
      • 7.3.4.1.2 China Pancrelipase Market by Distribution Channel
      • 7.3.4.1.3 China Pancrelipase Market by Application
    • 7.3.4.2 Japan Pancrelipase Market
      • 7.3.4.2.1 Japan Pancrelipase Market by Age
      • 7.3.4.2.2 Japan Pancrelipase Market by Distribution Channel
      • 7.3.4.2.3 Japan Pancrelipase Market by Application
    • 7.3.4.3 India Pancrelipase Market
      • 7.3.4.3.1 India Pancrelipase Market by Age
      • 7.3.4.3.2 India Pancrelipase Market by Distribution Channel
      • 7.3.4.3.3 India Pancrelipase Market by Application
    • 7.3.4.4 South Korea Pancrelipase Market
      • 7.3.4.4.1 South Korea Pancrelipase Market by Age
      • 7.3.4.4.2 South Korea Pancrelipase Market by Distribution Channel
      • 7.3.4.4.3 South Korea Pancrelipase Market by Application
    • 7.3.4.5 Singapore Pancrelipase Market
      • 7.3.4.5.1 Singapore Pancrelipase Market by Age
      • 7.3.4.5.2 Singapore Pancrelipase Market by Distribution Channel
      • 7.3.4.5.3 Singapore Pancrelipase Market by Application
    • 7.3.4.6 Malaysia Pancrelipase Market
      • 7.3.4.6.1 Malaysia Pancrelipase Market by Age
      • 7.3.4.6.2 Malaysia Pancrelipase Market by Distribution Channel
      • 7.3.4.6.3 Malaysia Pancrelipase Market by Application
    • 7.3.4.7 Rest of Asia Pacific Pancrelipase Market
      • 7.3.4.7.1 Rest of Asia Pacific Pancrelipase Market by Age
      • 7.3.4.7.2 Rest of Asia Pacific Pancrelipase Market by Distribution Channel
      • 7.3.4.7.3 Rest of Asia Pacific Pancrelipase Market by Application
• 7.4 LAMEA Pancrelipase Market
  • 7.4.1 LAMEA Pancrelipase Market by Age
    • 7.4.1.1 LAMEA Adults & Geriatrics Market by Country
    • 7.4.1.2 LAMEA Children Market by Country
  • 7.4.2 LAMEA Pancrelipase Market by Distribution Channel
    • 7.4.2.1 LAMEA Drug Store & Retail Pharmacies Market by Country
    • 7.4.2.2 LAMEA Hospital Pharmacies Market by Country
    • 7.4.2.3 LAMEA Online Pharmacies Market by Country
  • 7.4.3 LAMEA Pancrelipase Market by Application
    • 7.4.3.1 LAMEA Chronic Pancreatitis Market by Country
    • 7.4.3.2 LAMEA Cystic Fibrosis Market by Country
    • 7.4.3.3 LAMEA Others Market by Country
  • 7.4.4 LAMEA Pancrelipase Market by Country
    • 7.4.4.1 Brazil Pancrelipase Market
      • 7.4.4.1.1 Brazil Pancrelipase Market by Age
      • 7.4.4.1.2 Brazil Pancrelipase Market by Distribution Channel
      • 7.4.4.1.3 Brazil Pancrelipase Market by Application
    • 7.4.4.2 Argentina Pancrelipase Market
      • 7.4.4.2.1 Argentina Pancrelipase Market by Age
      • 7.4.4.2.2 Argentina Pancrelipase Market by Distribution Channel
      • 7.4.4.2.3 Argentina Pancrelipase Market by Application
    • 7.4.4.3 UAE Pancrelipase Market
      • 7.4.4.3.1 UAE Pancrelipase Market by Age
      • 7.4.4.3.2 UAE Pancrelipase Market by Distribution Channel
      • 7.4.4.3.3 UAE Pancrelipase Market by Application
    • 7.4.4.4 Saudi Arabia Pancrelipase Market
      • 7.4.4.4.1 Saudi Arabia Pancrelipase Market by Age
      • 7.4.4.4.2 Saudi Arabia Pancrelipase Market by Distribution Channel
      • 7.4.4.4.3 Saudi Arabia Pancrelipase Market by Application
    • 7.4.4.5 South Africa Pancrelipase Market
      • 7.4.4.5.1 South Africa Pancrelipase Market by Age
      • 7.4.4.5.2 South Africa Pancrelipase Market by Distribution Channel
      • 7.4.4.5.3 South Africa Pancrelipase Market by Application
    • 7.4.4.6 Nigeria Pancrelipase Market
      • 7.4.4.6.1 Nigeria Pancrelipase Market by Age
      • 7.4.4.6.2 Nigeria Pancrelipase Market by Distribution Channel
      • 7.4.4.6.3 Nigeria Pancrelipase Market by Application
    • 7.4.4.7 Rest of LAMEA Pancrelipase Market
      • 7.4.4.7.1 Rest of LAMEA Pancrelipase Market by Age
      • 7.4.4.7.2 Rest of LAMEA Pancrelipase Market by Distribution Channel
      • 7.4.4.7.3 Rest of LAMEA Pancrelipase Market by Application

Chapter 8. Company Profiles

• 8.1 Organon & Co.
  • 8.1.1 Company Overview
  • 8.1.2 Financial Analysis
  • 8.1.3 Regional Analysis
  • 8.1.4 Research & Development Expenses
• 8.2 Digestive Care, Inc.
  • 8.2.1 Company Overview
• 8.3 Laboratorio Opoterapico Argentino S.A.
  • 8.3.1 Company Overview
• 8.4 Scientific Protein Laboratories, LLC (Hepalink)
  • 8.4.1 Company Overview
• 8.5 AbbVie, Inc.
  • 8.5.1 Company Overview
  • 8.5.2 Financial Analysis
  • 8.5.3 Regional Analysis
  • 8.5.4 Research & Development Expense
  • 8.5.5 SWOT Analysis
• 8.6 Vivus LLC
  • 8.6.1 Company Overview
• 8.7 Nestle S.A
  • 8.7.1 Company Overview
  • 8.7.2 Financial Analysis
  • 8.7.3 Segmental and Regional Analysis
  • 8.7.4 Research & Development Expenses
  • 8.7.5 SWOT Analysis

Chapter 9. Winning Imperitives of Pancrelipase Market